APS Addendum No.1 - 72049723APS00001 - BEBAS TB.pdf

Issuance Date:

Ques ons Due Date and Time:

February , 2023

February 23, 2023; 10:00 AM, Jakarta Time

Closing Date and Time to submit Concepts: March 30, 2023; 10:00 AM, Jakarta Time

Federal Assistance Lis ng Number: 98.001 Foreign Assistance for Programs Overseas

Subject: APS Addendum No. 1 under the exis ng Accelera ng Elimina on of TB in Indonesia, APS No. 72049723APS00001

Opportunity Title: Bersama Menuju Eliminasi dan Bebas dari TB (BEBAS-TB)

Dear Interested Applicants:

Pursuant to the authority granted in the Foreign Assistance Act of 1961, as amended, the United States Government (USG), represented by the United States Agency for Interna onal Development (USAID), the Indonesia Mission, is announcing the first addendum issued under the Accelera ng Elimina on of TB in Indonesia APS for the “BEBAS-TB” ac vity that will support all seven objec ves under the APS within two selected provinces in Indonesia.

Through this BEBAS-TB APS Addendum, USAID Indonesia disseminates informa on to interested applicants so they may develop and submit Concept Papers in response to and to be considered for USAID funding. This Addendum describes and provides:

● The type of ac vi es for which Concept Papers will be considered;

● Available funding, process and requirements for submi ng Concept Papers;

● The Criteria for evalua ng Concept Papers; and

● Other informa on and documenta on or resources required for this Addendum

Issuance of this APS Addendum does not cons tute an award or commitment on the part of the USG, nor does it commit the USG to pay for costs incurred in the prepara on and submission of concept papers or applica ons. Issuance of award is subject to the availability of funds and the interest and requirements of USAID, as well as the viability of eventual Full Applica on(s) received.

U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT

U.S. Embassy Jakarta Jl. Medan Merdeka Selatan 3-5 Jakarta 10110, Indonesia USAID.gov

APS Addendum No. 1 – BEBAS TB

Based on the submi ed Concept Paper, USAID Indonesia will determine whether to request a Full Applica on from an eligible organiza on. To be compe ve, the Concept Paper submission must be fully responsive to all direc ons under this Addendum, and the overall APS except when specifically noted otherwise in this Addendum.

To be eligible for award, the Applicant must provide all informa on as required and meet eligibility standards of this APS. This funding opportunity is posted on www.sam.gov and www.grants.gov , and may be amended. It is the responsibility of the Applicant to ensure that the en re “umbrella” APS and APS Addendum have been downloaded from either of the websites in its en rety as USAID bears no responsibility for data errors resul ng from transmission or conversion process. In case of difficulty registering on www.grants.gov or accessing the APS, please contact the grants.gov Helpdesk at 1-800-518-4726 or via email at support@grants.gov for technical assistance.

All submissions (including ques ons) must be emailed to the Point of Contact indicated at Sec on D of this addendum by the date and me indicated on this cover le er. Responses to ques ons received prior to the deadline will be furnished to all poten al applicants through an amendment to this no ce posted on www.sam.gov and www.grants.gov

Thank you for your interest in USAID Indonesia programs.

Sincerely, Mohib Ahmed Supervisory Agreement Officer Office of Acquisi on and Assistance USAID/Indonesia

Mohib Ahmed

Digitally signed by Mohib Ahmed Date: 2023.02.07 19:09:08 +07'00'

TABLE OF CONTENTS

ACRONYMS

SECTION A – PROGRAM DESCRIPTION

SECTION B – FEDERAL AWARD INFORMATION 15

1. ESTIMATE OF FUNDS AVAILABLE AND NUMBER OF AWARDS CONTEMPLATED 15

2. START DATE AND PERIOD OF PERFORMANCE FOR FEDERAL AWARD 15

3. AWARD TYPE AND SUBSTANTIAL INVOLVEMENT 15

SECTION C – ELIGIBILITY INFORMATION 18

ELIGIBILITY APPLICANTS 18

SECTION D – CONCEPT PAPERS SUBMISSION INFORMATION 19

1. AGENCY POINT OF CONTACT (POC) 19

2. QUESTIONS AND ANSWERS 19

3. APPLICATION PROCESS 19

4. PROJECT DESIGN, MONITORING, EVALUATION AND LEARNING 19

SECTION E – CONCEPT PAPERS MERIT REVIEW INFORMATION 21

1. REVIEW OF CONCEPT PAPERS 21

2. MERIT REVIEW CRITERIA 21

3. ADDITIONAL CONSIDERATIONS 22

4. EVALUATION METHODOLOGY 22

SECTION F – FEDERAL AWARD ADMINISTRATION INFORMATION 23

1. FEDERAL AWARD NOTICES 23

2. REPORTING REQUIREMENTS 23

APPENDIX I - CONCEPT PAPER TEMPLATE 24

ACRONYMS

ACF Active Case Finding

ADS Automated Directives System

AO Agreement Officer

AOR Agreement Officer’s Representative

APS Annual Program Statement

CDCS Country Development Cooperation Strategy

CFDA Catalog of Federal Domestic Assistance

CFR Code of Federal Regulations

DO Development Objective

DR TB Drug Resistant TB

FAA Federal Foreign Act

FAA Fixed Amount Award

GoI Government of Indonesia

ICS Integrated Country Strategy

HSS Health System Strengthening

MoH Ministry of Health

MDR TB Multidrug Resistant Tuberculosis

NGO Non-governmental Organization

NTP National Tuberculosis Program

OAA Office of Acquisition and Assistance

PoC Point of Contact

SDG Sustainable Development Goal

TB Tuberculosis

TPT TB preventive treatment

USAID United States Agency for International Development

SECTION A – PROGRAM DESCRIPTION

This Addendum calls for Concept Papers for BEBAS-TB activity. This Addendum is issued under the existing Accelerating Elimination of TB in Indonesia Annual Program Statement, APS No 72049723APS00001. All interested organizations should carefully review both the Addendum and the APS.

This funding opportunity is authorized under the Foreign Assistance Act (FAA) of 1961, as amended. The resulting awards will be subject to 2 CFR 200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, and USAID’s supplement, 2 CFR 700, as well as the additional requirements found in Section F of this APS.

A. Background & Problem Statement

Please refer to the Accelerating Elimination of TB in Indonesia APS as the country context is provided there.

B. Activity Description

BEBAS-TB will be the first addendum issued under the Accelerating Elimination of TB in Indonesia APS. BEBAS-TB will support all seven objectives under the APS within two selected provinces in Indonesia (to be determined at a later time in consultation with the Ministry of Health). In publishing this Addendum, USAID is seeking responses from eligible organizations to achieve the following objectives in collaboration with the MOH, Global Fund, and other relevant development partners working in TB.

C. Theory of change

Interested organizations will be requested to develop and include a theory of change in the concept notes they submit in response to this addendum.

D. Goal and Objectives

Goal: To assist the Government of Indonesia in addressing the TB epidemic and achieving 2030 TB elimination targets.

Objectives:

1. Enhanced capacity for TB case finding IR 1.1. Active TB case finding scaled up in facilities IR 1.2 TB detection among high-risk groups and underserved populations improved in communities

IR 1.3 Childhood TB screening and detection expanded IR 1.4 Contact investigation increased and expanded

2. Improved quality of TB screening and diagnosis IR 2.1 Novel digital radiological screening and laboratory technologies introduced IR 2.2 Quality of TB laboratory services and diagnostic tools improved IR 2.3 TB diagnostic network and connectivity solutions expanded

3. Improved quality of TB service delivery IR 3.1 Effective adherence tools introduced and treatment monitoring improved IR 3.2 Primary health care for provision of integrated DS and DR-TB services explored IR 3.3 Quality TB care expanded IR 3.4 Novel TB treatment regimens scaled up

4. Prevention of TB optimized IR 4.1 Testing for TB infection strengthened IR 4.2 Delivery of TB preventive therapy for all eligible populations expanded IR 4.3 Infection Prevention and Control (IPC) implemented across all settings IR 4.4 TB prevention campaigns sustained

5. Strong and resilient health system to accelerate TB elimination IR 5.1 Financing mechanism for TB control sustained IR 5.2 Health information system for TB enhanced IR 5.3 TB drugs and commodities secured

6. Community participation in implementing development activities strengthened IR 6.1 Partnership with communities in designing, implementing and monitoring TB program leveraged

7. Implementation research to improve TB control

1. Enhanced capacity for TB case finding

At the national level, the activity will be expected to provide technical assistance to the national TB program with a focus on scaling up proven approaches, introducing innovations in case finding strategies, and supporting policy development and implementation in alignment with international standards. The activity will also support dissemination of new regulations and evidence-based initiatives across Indonesia.

For the subnational level, the activity will be expected to implement the following IRs:

IR 1.1 Active TB case finding scaled up in facilities

The Activity will assist the NTP in improving TB case detection rates by scaling up an effective active case finding (ACF) approach at the facility level, therefore addressing missed opportunities to find TB cases and reduce delays in providing prompt treatment to TB patients.

If deemed appropriate to the situation, integrated COVID-19 and TB screening would be continued as per national guidelines. This intervention will include efforts to ensure early diagnosis to those who are suffering from TB without the typical symptoms. For this purpose, the activity will build upon lessons learned from past and ongoing USAID investments in the TB program in countries with similar contexts with Indonesia.

IR 1.2 TB detection among high-risk groups and underserved populations improved in communities

This activity will improve and expand community base active case finding approaches among high risk and marginalized groups. This includes promoting screening for TB infection and disease among these high risk and underserved groups and people living in hard-to-reach areas and requiring TB screening outreach in their communities.

IR 1.3 Childhood TB screening and detection expanded

This activity will support the NTP in addressing systemic challenges with detecting TB among children (especially child contacts of adult TB patients), implement novel or improved technologies for TB testing and diagnosis among children. This activity will work with local health authorities to strengthen TB diagnosis in children by increasing access to innovative rapid molecular testing and improving the health system’s capacity for clinical diagnosis.

IR 1.4 Contact investigation increased and expanded

Evidence suggests that each patient with active TB disease, before enrollment on appropriate treatment can infect as many as 10 close contacts per year. However, screening and testing for TB among household and close contacts in Indonesia requires significant attention and expansion. This activity will assist local health authorities to plan and implement effective TB contact investigation strategies.

2. Improved quality of TB screening and diagnosis

At the national level, the activity will be expected to provide technical assistance to the national TB program with a focus on utilizing the most accurate tools to screen and diagnose individuals for TB, particularly rapid molecular diagnosis. This activity will support NTP to introduce innovations based on global evidence and best practices in TB screening and diagnosis and to develop strategies and policy development according to international standards. The activity will also support dissemination of new regulations and evidence-based initiatives across Indonesia.

For the subnational level, the activity will be expected to implement the following IRs:

IR 2.1 Novel digital radiological screening and laboratory technologies introduced

According to the latest TB Prevalence Survey, as many as 40% of people with TB in Indonesia do not have specific TB symptoms. Therefore, this activity will implement cost effective and systematic TB screening interventions and increase access to new technologies such as portable digital x-ray with artificial intelligence (AI). Also, in order to support the TB diagnosis confirmation, the activity will support the NTP of Indonesia to scale up rapid molecular tests, bring novel diagnostic technologies and promote the implementation of new diagnostic platforms that are easily available and affordable for TB patients. The activity will also improve specimen transport as well as patient referral systems for both public and private providers.

IR 2.2 Quality of TB laboratory services and diagnostic tools improved

This activity will support the National Referral Laboratories (NRLs) and NTP as well as laboratories at the provincial and district level to maintain quality standards, introduce new measures to maintain quality and provide support for continuous quality assurance. Also, the activity will support local health authorities with providing needed capacity building to professional staff and establishing linkages between laboratories on different system levels.

IR 2.3 TB diagnostic network and connectivity solutions expanded

This activity will support local health authorities to improve rapid and accurate diagnosis of TB using a reliable, well-organized, and effectively operated diagnostic network. This activity will work to improve all levels of the TB laboratory hierarchy: from microscopy smear sites to rapid molecular tests, to DST and whole genome sequencing, and will also include strengthening TB laboratories in the private sector. In addition, this activity will work on the screening and diagnostic connectivity network including X-ray stations, where screening for TB is performed as well as ensuring sample transportation systems are reliable and reporting is done in real-time.

3. Improved quality of TB service delivery national TB program with a focus on improving the quality of TB service delivery for both DS-and DR-TB care, introducing and piloting new approaches and treatment regimens, and bringing international best practices to the country. Provided support will be focused on assisting policy and guidelines development and dissemination of these materials across the country.

For the subnational level, the activity will be expected to implement the following IRs:

IR 3.1 Effective adherence tools introduced and treatment monitoring improved

As there are multiple factors influencing the TB epidemic, there is an increased need to apply a patient-centered model to achieve universal access to quality TB care for all. Understanding that treatment adherence is the cornerstone of good treatment outcomes, expanded use and fine tuning of innovative solutions such as digital adherence monitoring tools, social and psychological support, and counseling are needed to sustain good-quality programs. This Activity will also support incorporation of social support for TB patients into patient-centered TB care, including integrating patient support into TB care management to improve treatment completion, management of adverse drug reactions, and prevention of treatment interruption which leads to development of drug resistant TB.

IR 3.2 Primary health care for provision of integrated DS and DR-TB services explored

TB care service delivery in Indonesia is organized via hospitals and primary health care (PHC) facilities, where patients are not only diagnosed, but also enrolled on appropriate treatment and supported throughout the treatment journey. However, DR-TB care historically has been organized via parallel structures due to its complexity and needed attention to the adverse drug reactions that patients experience. With the DR-TB treatment becoming all-oral and shorter, a full integration of DS- and DR-TB care will allow true patient-centered treatment delivery at the PHC level. At the same time, PHCs have multiple other responsibilities for delivering essential care to adults and children and project support would be needed to assist health staff to transition to a new structure, gain new knowledge and skills. This activity will provide educational and technical support to selected districts to pilot a comprehensive model of TB service delivery and generate evidence to support future implementation and scale-up.

IR 3.3 Quality TB care expanded

While the national average for treatment success rate for DS-TB remains high, a further gap analysis and targeted improvement in underperforming districts is needed. For DR-TB, a number of essential programmatic gaps have persisted over the last several years, including:

high rates of initial lost-to-follow up, poor treatment adherence and low treatment success rates for both adults and children. The activity will adopt and leverage learnings derived from USAID’s work in integrating community-based DR-TB support into clinical-centered care, and explore opportunities to expand the model to public health systems and other non-governmental health care settings. Additionally, to ensure continuity of care for TB patients with comorbidities, the activity will assist in pursuing joint collaboration between TB and other diseases/health issues, e.g., HIV, MNH, and diabetes mellitus, to build an integrated model of care.

IR 3.4 Novel TB treatment regimens scaled up

In the last couple of years, several novel treatment regimens for DS- and DR-TB have been introduced and approved by the WHO. All of them are shorter in duration and include all-oral medications, which will allow easier treatment administration and better compliance from the patients’ side. Quick uptake and rapid scale up of the novel regimens will allow NTP to increase treatment coverage while improving treatment results for both adults and children. This activity will help to scale up selected regimens in priority districts in public and private clinics.

4. Prevention of TB optimized national TB program in introducing novel TB infection (TBI) diagnostic and screening tools, pilot and evaluate the effectiveness of the new approach for TB prevention treatment (TPT), followed by assisting the NTP in developing/updating evidence-informed policies based on global recommendations and support the dissemination of evidence-based TB prevention initiatives across Indonesia.

As for subnational level, the activity is expected to implement the below IRs:

IR 4.1 Testing for TB infection strengthened

Indonesia introduced testing for TBI several years ago, however it is still implemented at a small scale through donor-supported activities. The Indonesia NSP reflects ambitious goals for TPT initiation, but these goals cannot be achieved without several essential elements, one of which is testing for TB infection. This activity will help leverage efficient laboratory practices to perform TBI tests, explore collaboration models between the secondary and primary health care in optimizing TBI management, generate most feasible approaches for better TPT coverage and rapidly roll it out in the priority areas.

IR 4.2 Delivery of TB preventive therapy for all eligible populations expanded

Timely and appropriate TPT along with contact investigation are essential components of epidemic control. The Activity will assist in securing supply of TPT drugs at health facilities and increase uptake of new and shorter TPT regimens by eligible populations. To ensure reliable access for TB screening and preventive treatment to all risky individuals, this activity will also support in promoting integration with other health programs, such as HIV, diabetes, and etc.

for seamless access to TB screening and TPT administration among the immunocompromised individuals.

IR 4.3 Infection Prevention and Control (IPC) implemented across all settings

One of the important components of TB prevention is Infection Prevention and Control (IPC) activities aimed at preventing air particles containing mycobacteria to reach healthy individuals via personal, administrative, or environmental measures. While an integration of IPC to prevent TB transmission has long been included in the national TB program, adoption of the approach across the health care system in Indonesia remains inadequate. With the increasing involvement of public - private providers and local organizations in TB activities, this activity will assist adapting the national IPC policies into subnational action plans that include administrative, environmental, and personal protective measures in health facilities, congregate settings, communities, and households. Moreover, this activity will also assist in translating the strategy into IPC activities in various settings to minimize TB transmission.

IR 4.4 TB prevention campaigns sustained

The disruption of the entire health system caused by the COVID-19 pandemic garnered significant public attention and provided an opportunity to improve understanding about the disease. The pandemic provided examples of the essential contribution of health education in fighting the infectious disease by promoting protective behaviors. Building on the models of consolidated public health education during the COVID-19 crisis, this activity will assist in leveraging health promotion about TB, particularly in ensuring that a wealth of information about TB is available to the public. Multisector coordination should be a substantial component in rolling out the intervention to ensure the effective delivery of key TB messages across all sectors. Additional emphasis under this sub objective will be increased efforts in educating communities about TPT to advance awareness and acceptability among the targeted beneficiaries and health providers. In support of this effort, this Activity will work in robust collaboration with another USAID activity, PREVENT TB, to increase demand for TPT through a behavior change communication intervention.

5. Strong and resilient health system to accelerate TB elimination national TB program to address key elements in the health system components influencing TB response in the country, such as health financing, supply chain management, health information system, and human resource development. Provided support will be focused on assisting with the development of policies, norms and regulation and dissemination of them across the country, as well as developing innovative digital solutions for capacity building. To sustain and increase political commitment, this activity will assist local players to form local TB partnerships at the district and province levels and provide needed support to the national Stop TB partnership to be active and sustainable. In addition, this activity will partner and collaborate with Kemenko PMK to support the national and sub-national network of CSOs and patients’ organizations.

For the subnational level, the activity will be expected to implement the following IRs:

IR 5.1 Financing mechanism for TB control sustained

Funding for TB control in Indonesia continues to fall short of the estimated funds needed to achieve optimal TB targets. Even before the COVID-19 crisis, the establishment of a robust social protection system that effectively mitigated catastrophic costs due to TB remained lacking. The pandemic worsened financing for TB activities by distorting health spending priorities at multiple levels.

This activity will continue supporting the country’s ongoing efforts in exploring innovative financing mechanisms that ensure equitable access to a wide range of TB services, thereby eliminating catastrophic costs due to considerable out-of-pocket expenses incurred for accessing TB care. While this intervention is ideally incorporated into Indonesia's National Health insurance scheme, this activity will also have the ability to anticipate additional local financing mechanisms aimed at securing financial support for TB patients and supporting local organizations to implement TB activities that contribute to improved TB outcomes.

IR 5.2 Health information system for TB enhanced

SITB, the current national TB surveillance system introduced in 2020 and scaled up nationwide, requires continued actions to improve its functionality. In addition, many other digital TB applications, namely, WIFI TB which simplified TB reporting by General Practitioners (GPs) and private clinics, connectivity solutions such as Epicenter and GXAlert that provided immediate TB test results to providers, and SOBAT TB, a digital mobile app for TB self-screening and diagnosis referral, require further refinement. These systems lack interoperability to facilitate efficient TB recording/reporting and data maintenance by both public and private health providers. The use of accurate information generated by these systems is essential to inform strategic and timely decision making at all levels. This activity will collaborate with USAID’s Country Health

Information Systems and Data Use (CHISU) activity, implemented by JSI, to continue efforts to improve optimal SITB operations while ensuring alignment of USAID support on digital TB technology(ies) with the most recent GoI policy on digital health transformation led by the Center for Data and Information (Pusdatin) through the Digital Transformation Office (DTO).

IR 5.3 TB drugs and commodities secured

Successful TB management requires strengthening of the entire health system, including supply chain management to ensure uninterrupted supply of quality assured TB drugs and commodities to TB patients whenever they are needed. For this, the availability of a strong system in forecasting, procurement, tracking and monitoring the supply chains of TB drugs and commodities is pivotal. This Activity will support provincial and district health offices with improving the TB supply chain management system so that it allows for reliable forecasting methods, drug quality assurance, timely distribution of drugs and commodities, and prevention of overstocking and drug stock outs. In addition, this activity will work with both public and engaged private facilities to prevent stockouts of medicines and supplies.

6. Community participation in implementing development activities strengthened

A successful TB program requires both the government and community to actively take responsibility in planning, implementing, and monitoring TB control activities. Therefore, at the national level, this activity will be expected to work in partnership with key stakeholders and communities to strengthen the capacity of organizations for TB control and promote supportive regulation and resources for broader community involvement.

For the subnational level, the activity will be expected to implement the following IRs:

IR 6.1 Partnership with communities in designing, implementing and monitoring TB program leveraged

This activity will engage communities in shaping policy on patient-centered programs, delivering quality community-based TB care, and advancing the community’s potential in other TB management roles. This activity will include strengthening the role of the community in TB detection and treatment, gaining new technical knowledge, utilizing novel diagnostic and treatment technologies and obtaining new practical skills.

7. Implementation research to improve TB control

This objective will provide targeted technical support at the national level only. The activity will be expected to provide technical assistance to the Ministry of Health to plan, conduct operational research activities and analyze and use data derived from this research. Also, it will identify prominent TB research centers across the country, provide capacity building and technical assistance for performing OR studies on key topics relevant to the TB situation. In addition, this Activity will promote stronger collaboration between the national TB research https://chisuprogram.org/ https://chisuprogram.org/ network (JETSET TB), research centers, academia, and national TB stakeholders in translating the evidence generated by their members into policies that align with TB program priorities.

E. Geographic Focus

The proposed geographic locations for the Accelerating Elimination of TB in Indonesia APS are North Sumatra, Banten, DKI Jakarta, West Java, Central Java, East Java, and South Sulawesi provinces. The selections are based on the highest TB burden provinces and prioritized within the eight priority provinces under USAID’s Country Development Cooperation Strategy (CDCS) 2020-2025 and the next CDCS. This Activity, BEBAS-TB, will support all seven objectives under the APS within two selected provinces in Indonesia (to be determined at a later time in consultation with the Ministry of Health). BEBAS-TB will work in at least 50% of the number of districts based on its TB burden in the selected provinces. During implementation, USAID reserves the right to adjust the geographic focus based on disease burden or responding to the host government's request.

F. Private Sector Engagement

Applicants will be expected to explore potential collaborations that leverage private sector funding/co-investment with USAID/Indonesia for the TB control program. In addition, applicants will need to envision the role of the private sector (including but not limited to private healthcare providers, laboratories, clinics, pharmacies, businesses, corporations, small or medium enterprises or firms, relevant industry/business associations, chambers of commerce, and other private sector entities, as they are deemed relevant) in the BEBAS-TB activity to achieve the activity goal.

Expected Results:

The Accelerating Elimination of Tuberculosis in Indonesia APS aims to contribute to an overall decline in TB incidence, prevalence, and mortality in Indonesia

At minimum, this Activity BEBAS-TB, will also list, monitor, and report on the following USAID standard indicators1:

● TB Detection Rate

● Childhood TB Notifications

● Private Sector TB Notifications

● Contact Investigation Coverage Rate

● TB Preventive Treatment (TPT) enrollment

● Proportion of Domestic Financing for TB

● Drug-Resistant TB Notifications

1https://www.usaid.gov/global-health/health-areas/tuberculosis/resources/news-and-updates/global-accelerator-end-tb/pbmef https://www.usaid.gov/global-health/health-areas/tuberculosis/resources/news-and-updates/global-accelerator-end-tb/pbmef https://www.usaid.gov/global-health/health-areas/tuberculosis/resources/news-and-updates/global-accelerator-end-tb/pbmef

● Drug-Resistant TB Treatment Success Rate

● TB Treatment Success Rate

● Bacteriological Diagnosis Coverage Rate - Pulmonary TB

[End of this Section]

SECTION B – FEDERAL AWARD INFORMATION

This APS Addendum is calling for concepts submission, with the deadline indicated in the cover page. All interested organizations should carefully review both the umbrella APS Number 72049723APS00001 for the Accelerating Elimination of Tuberculosis (TB) in Indonesia as well as this Addendum. Important information contained in the umbrella APS is not repeated in the Addendum.

1. ESTIMATE OF FUNDS AVAILABLE AND NUMBER OF AWARDS CONTEMPLATED

Subject to availability of funds, USAID Indonesia anticipates awarding one (1) Cooperative Agreement under this Addendum with a total estimated budget not to exceed $70,000,000.

All funding will be provided on an incremental basis subject to the availability of funds and successful performance. USAID reserves the right to change the funding amounts, cycle, and terms of the agreement as a result of availability of funding, USG requirements or recipient performance. Should such changes occur, the recipient will be notified accordingly.

2. START DATE AND PERIOD OF PERFORMANCE FOR FEDERAL AWARD

The anticipated period of performance for an award made under this Addendum is five (5) years.

3. AWARD TYPE AND SUBSTANTIAL INVOLVEMENT

The award resulting from this Addendum is a Cooperative Agreement. The Cooperative Agreement will contain substantial involvement. This substantial involvement will be through the Agreement Officer (AO), except to the extent that the AO delegates authority to the Agreement Officer’s Representative (AOR) in writing. The intended purpose of the substantial involvement during the award is to assist the recipient in achieving the supported objectives of the agreement. The Cooperative Agreement may have some or all the following substantial involvement.

● Approval of the Recipient’s Annual Implementation Plans/work Plans

The Annual Implementation Plan, and any subsequent revisions, are subject to approval by the AOR prior to implementing substantive work for each year of the Agreement. The annual implementation plan communicates how and when the recipient will complete project activities. This plan will be developed in partnership between the recipient and the

AOR team. The AOR will ensure that the implementation plans fit within the scope, goals, terms and conditions of the agreement.

● Approval of Specified Key Personnel

The key personnel positions will be determined during the co-creation phase. Key personnel positions will require concurrence from the AOR and approval from the Agreement Officer (AO). Maximum five positions are considered as key personnel.

● Agency and Recipient Collaboration or Joint Participation

3.1 Approval of recipient’s monitoring and evaluation plans

This describes USAID involvement in monitoring progress toward the achievement of program objectives during the performance of the project, including written guidelines for the content of annual reports and final evaluations.

While an illustrative Activity Monitoring, Evaluation, and Learning (MEL) Plan could be requested in the full application submission, the final Activity MEL Plan will be developed in consultation with USAID post-award. During the initial project planning period, the awardee will work closely with USAID to establish major milestones, program monitoring indicators, as well as baseline data and performance targets which will demonstrate successful achievement of the results addressed in the cooperative agreement.

3.2 Collaborative involvement in selection of advisory committee members

If the program establishes an advisory committee that provides advice to the recipient, USAID will participate as a member of this committee. Advisory committees must only deal with programmatic or technical issues and not routine administrative matters.

3.3 Concurrence on the substantive provisions of sub-awards

The recipient must obtain AO’s prior approval for the sub-award, transfer, or contracting out of any work under an award. The term ‘sub-awards’ includes both sub-agreements and contracts under assistance. Some of the sub-award approval responsibilities may be delegated to the AOR. Please note that any sub-awards (sub-agreements or contracts) to foreign governmental organizations or parastatals of any amount must be approved by the AO and may warrant additional clearances.

3.4 Monitor to authorize specified kinds of direction or redirection because of interrelationships with other projects

Activities will be included in the program description, negotiated in the budget, and made part of the award. Note: the AOR will provide review of the proposed change, and the AO is the only individual who can provide approval for this element of substantial involvement

● Agency Authority to Immediately Halt an Activity

The AO may immediately halt an activity when identified specifications are not met.

SECTION C – ELIGIBILITY INFORMATION

ELIGIBILITY APPLICANTS

Only U.S. Organizations from the authorized geographic code (937) may participate under this Addendum. USAID will not accept applications from individuals. All applications must be legally recognized organization entities under applicable law.

U.S faith-based organizations are eligible to apply for federal financial assistance on the same basis as any other organization and are subject to the protections and requirements of Federal law.

SECTION D – CONCEPT PAPERS SUBMISSION INFORMATION

1. AGENCY POINT OF CONTACT (POC)

The POC for information about this Addendum is:

Ms. Yulian Christanti A&A Specialist Office of Acquisition and Assistance (OAA) USAID Indonesia Email at applications-indonesia@usaid.gov and cc to ychristanti@usaid.gov

2. QUESTIONS AND ANSWERS

All questions regarding this Addendum should be submitted in writing via email with a subject line of “APS Addendum BEBAS-TB Questions” only to the email address identified above by the deadline stated on the cover page.

3. APPLICATION PROCESS

PHASE 1: CONCEPT PAPERS SUBMISSION AND REVIEW

Appendix 1 provides a Concept Paper Template for Applicants to submit in writing via email to the assigned POC listed above by the closing date indicated in the cover page of this Addendum.

Upon the closing date, concept papers will be evaluated against the merit review criteria as described in SECTION E of this Addendum.

PHASE 2: FULL APPLICATION BY INVITATION ONLY

USAID will only accept a full application from the apparently successful applicant. USAID will issue a Request for Full Application (RFA) and will provide complete instructions for submission.

NOTE: At its sole discretion, USAID reserves the right to conduct co-creation at any stages, before or after the submission of full application.

4. PROJECT DESIGN, MONITORING, EVALUATION AND LEARNING

The ability to effectively monitor activities, evaluate their impact, and learn from the experience depends on the thoughtful and methodologically rigorous approach to project design. USAID seeks solutions that demonstrate robust design grounded in an efficient and mailto:applications-indonesia@usaid.gov mailto:ychristanti@usaid.gov logical theory of change (TOC), tightly linked to appropriate activities and corresponding performance and impact indicators.

Note that, regardless of the design activities, proposed activities will be designed to be able to report on USAID foreign standard indicators. Additional indicators that serve this purpose will be determined through potential co-creation and activity design for each area, and their appropriateness will depend on local context and the nature of the activity. All selected indicators will be sourced from a standard list of USAID TB indicators found here:

https://www.usaid.gov/global-health/health-areas/tuberculosis/resources/news-and-updates/global-accelerator-end-tb/pbmef

SECTION E – CONCEPT PAPERS MERIT REVIEW INFORMATION

1. REVIEW OF CONCEPT PAPERS

USAID will evaluate concept papers and decide whether to engage applicants further. Based on the outcome of the evaluation concepts will either receive conditional acceptance or rejection.

If rejected no further information will be requested or accepted from the applicant. The conditionally accepted concept may be invited to engage further in co-creation or to submit a full application.

In addition, competitive concepts should address most if not all of the concept paper template in Appendix 1- Concept Paper Template.

2. MERIT REVIEW CRITERIA

Concept papers will be evaluated based on the criteria outlined below, which are of equal importance. See Appendix 1 on how to submit the concept papers.

Criterion 1- Technical Approach

The relevancy of the applicant’s approach in covering all of the seven objectives to assist the GOI in addressing the TB epidemic and advancing progress toward 2030 TB elimination targets.

The degree to which innovations and best practices introduced are viable and will lead to the overall objectives. The extent to which the beneficiaries and selected districts will contribute to the national TB control performance.

Criterion 2- Monitoring, Evaluation, and Learning

The extent to which the applicant demonstrates a robust design grounded in an efficient and logical theory of change (TOC). The extent to which the results are clearly defined and will lead to the successful achievement of the objectives and are tightly linked to appropriate activities.

The extent to which the applicant’s strategy will feasibly and effectively measure, evaluate, and report on results.

Criterion 3 - Partners and Institutional Capacity The degree to which the applicant clearly outlines its roles and responsibilities and of its sub awardees or key partners. Further, the extent to which the strengths and capabilities of the proposed partners are complementary and not duplicative. The degree to which the management approach, staffing plan, and organizational chart demonstrate the capability to successfully implement the proposed technical approach.

3. ADDITIONAL CONSIDERATIONS

In addition to alignment with the U.S. Government Global TB Strategy and the National TB Strategy for TB Care and Prevention in Indonesia, applicants should ensure that their concepts are aligned with other relevant USAID strategies, policies, and priorities.

4. EVALUATION METHODOLOGY

USAID will utilize a “Confidence” rating methodology to evaluate concept papers received.

The below chart details the rating scheme and the definitions that apply to the merit review criteria:

SECTION F – FEDERAL AWARD ADMINISTRATION INFORMATION

1. FEDERAL AWARD NOTICES

The USAID Agreement Officer (AO) is the only individual who may legally commit the U.S.

Government to the expenditure of public funds. USAID will administer awards in accordance with 2 CFR 200, 2 CFR 700, and Standard Provisions for U.S. Non-Governmental Organizations.

2. REPORTING REQUIREMENTS

Reporting requirements will be determined later in a request for full application. For illustrative reporting requirement, a Cooperative Agreement will have some or all the following reporting requirements:

● Annual Implementation/Work Plans

● Quarterly Performance/Progress Reports

● Annual Performance Reports

● Financial Reports

● Annual Monitoring, Evaluation and Learning Plan

● Closeout/Demobilization Plan

● Final Report

● Ad-Hoc Reporting or Special Reporting to the Government of Indonesia

APPENDIX I - CONCEPT PAPER TEMPLATE

Please note for the standard template information that:

● The Applicants must submit the concept papers following the template described below. No annexes or appendixes will be considered.

● USAID will not review any pages in excess of the page limits noted in the subsequent sections. Please ensure that your submissions comply with the page limitations. All pages must be numbered.

● Submissions must be submitted in English.

● Use standard 8½” x 11”, single sided, single-spaced, 12-point Calibri font, 1” margins, left justification and headers and/or footers on each page including consecutive page numbers.

● 10-point font can be used for graphs and charts. Tables, however, must comply with the 12-point Calibri requirement.

● Submitted via Microsoft Word or PDF formats, except for the one-page budget summary can be submitted in Microsoft Excel or PDF formats.

SECTION A - Cover Letter and Applicant Information:

(Maximum 1 page)

1. BEBAS-TB Activity Title

2. Prime Applicant Name and Contact Information

3. Key Partner/Sub-Awardee Organizations

4. UEI and SAM Registration Number or Status

SECTION B - TECHNICAL APPROACH

(Maximum 6 pages)

1. What is your proposed approach to accomplish all seven of the stated objectives in the program description and how will your proposed approach achieve the program’s overarching goal? Please describe how your proposed interventions will work at the national and subnational levels and catch up with national TB targets.

2. Related to your proposed approach in question one, what innovations and best practices will your organization introduce?

3. Who will benefit from your approach? Please describe the estimated population reached and the key groups that will be targeted.

4. How many districts do you anticipate to cover under your proposed technical approach?

Please also explain how your proposed approach in the selected districts will contribute to the national TB control performance.

SECTION C - MONITORING AND EVALUATION

(Maximum 3 pages)

1. What is the theory of change for your organization’s approach? Please frame your theory of change (TOC) as an if then statement and describe the assumptions and risks behind the TOC.

2. What results will your organization achieve through your proposed approach? Please describe the indicators your organization aims to achieve per objective and intermediate results. You may suggest additional intermediate results if deemed appropriate.

3. What is your monitoring, evaluation, and learning strategy that demonstrates how progress and results will be monitored, evaluated and reported?

4. A one-page diagram of high-level TOC translated into a results framework. This diagram will follow the general TOC guidance listed in SECTION D.3 above, showing at a high-level how proposed activities will synergize for the proposed outcomes, and how activities might be monitored to detect problems and/or report progress.

SECTION D- PARTNERS AND INSTITUTIONAL CAPACITY

(Maximum 2 page)

1. What are your roles and responsibilities and that of your sub awardees or key partners in implementing the proposed activities? How will you leverage their institutional strengths and capabilities in support of the program description?

2. How will your organization’s management approach lead to successful achievement of the program’s objectives and overarching goal? Please include a staffing plan and organizational chart that demonstrate capability to successfully implement the proposed technical approaches.

[End of APS Addendum]

APPENDIX I - CONCEPT PAPER TEMPLATE